News Related to Cartilage Thickness

Related coverage linked through entity extraction aliases.

Cynata raises $1.5 million ahead of Phase 3 osteoarthritis and Phase 2 aGvHD readouts

May 04, 2026

Cynata raised $1.5 million through a placement at $0.25 a share ahead of Phase 3 osteoarthritis and Phase 2 aGvHD trial readouts due in May and June 2026. Its aGvHD study has completed the 100-day primary evaluation period for all 65 participants.

Semaglutide Shows Promise for Osteoarthritis While SNAC Ingredient Raises Safety Questions

Feb 21, 2026

New research reveals semaglutide may directly repair cartilage in osteoarthritis patients, while a separate study raises concerns about SNAC, an ingredient used in oral semaglutide formulations, and its effects on gut health.